Strata Skin Sciences (NASDAQ:SSKN – Get Free Report) is anticipated to release its resultson Tuesday, November 17th. Analysts expect Strata Skin Sciences to post earnings of ($0.38) per share and revenue of $5.41 million for the quarter.
Strata Skin Sciences Stock Down 100.0%
The stock has a market cap of $1,000.00, a price-to-earnings ratio of -0.00 and a beta of 0.33. Strata Skin Sciences has a one year low of $0.00 and a one year high of $1.75. The company has a debt-to-equity ratio of 10.22, a quick ratio of 0.75 and a current ratio of 0.95.
About Strata Skin Sciences
Strata Skin Sciences, Inc is a medical technology company focused on developing and commercializing products for dermatology and aesthetic applications. Its portfolio is centered on light-based devices used by physicians to treat a range of skin conditions.
The company’s principal products include the XTRAC excimer laser system, which is used in the treatment of psoriasis, vitiligo and other localized skin disorders, and the VTRAC excimer lamp system for similar dermatological applications.
Read More
- Five stocks we like better than Strata Skin Sciences
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
